Category: biotech

4 4/3/2017

‘Fake breakthrough, fake news:’ One physician-researcher’s takeaway on news coverage of MS drug Ocrevus

8/23/2016

What journalists and consumers should know about the tug-of-war between biologics and generic ‘biosimilars’

1/13/2016

Grail’s search for a universal cancer screen: noble quest or fool’s errand?

1 1/12/2016

Hypewatch: Journalists need to pour some cold water into that “Grail”

3 7/27/2015

Fred Hutch president predicts cancer cure in 10 years; critics have heard it all before

22 4/6/2015

Money angle is missing from Post’s coverage of a new ALS drug

8 3/24/2015

Some journalists fire another “silver bullet” at Alzheimer’s amyloid target

2 3/23/2015

Sponsored journalist training on “precision medicine”: Zeroing in on a conflict of interest

2/25/2015

Why we look for independent perspectives in health/medicine/science news stories

2 2/23/2015

Stealth Research & “may they know the exact content of their stools”